McCormick & Company (MKC)
NYSEConsumer StaplesPackaged FoodsSnapshot 2026-07-07
$52.22+0.85%
Close 2026-07-07 · 1-day change
Reading MKC? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track MKC free→NYSEConsumer StaplesPackaged FoodsSnapshot 2026-07-07
Reading MKC? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track MKC free→McCormick integrates Unilever Foods well, targeting $600M cost synergies. Organic sales growth is steady at about 1.7% with pricing and volume gains. Profit margins are expanding, with operating income up 30% in Q2 and margin growth guided at 100-120 basis points. Strong cash flow supports dividends and financing plans.
The Unilever acquisition strains capital and management focus. Organic growth is modest and may not offset integration risks. Margin gains could stall if cost savings fall short or inflation pressures rise.
The market prices about 7.5% revenue growth and values shares near $53, slightly below our fair value. Our view aligns with consensus but sees risks in integration and margin sustainability.
Breaks if: free cash flow materially below 2025 level of $962 million
Obtain and manage financing facilities to support the combination with Unilever Foods and maintain disciplined capital allocation including dividends.
Standing thesis, reviewed periodically — not a price target or advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Stated in 2 of last 2 quarters. Management secured financing via Term Loan and Bridge Commitment Letter for the Unilever Foods transaction. They expect strong cash flow in 2026, supported by profit and working capital initiatives, and plan to return significant cash to shareholders via dividends. The priority is progressing with financing in place and cash flow generation consistent with plans.
“Entered into Term Loan Agreement and Bridge Commitment Letter to finance the pending combination with Unilever Foods.”
“Expect strong cash flow driven by profit and working capital initiatives and anticipate returning significant portion to shareholders through dividends.”
Breaks if: adjusted operating margin falls below 16.0%
Continue Comprehensive Continuous Improvement (CCI) program to improve cost savings, operational efficiency, and expand adjusted operating margins.
Stated in 6 of last 6 quarters. Adjusted operating income grew from $258.6M in 2025-Q2 to $336.4M in 2026-Q2 (+30%), with margin expansion guidance of 100 to 120 basis points for 2026. Management consistently credits the CCI program for cost savings and margin expansion. The trajectory is delivering consistent margin improvement.
“CCI program led cost savings contributed to adjusted operating income growth and margin expansion.”
“Cost savings led by CCI program, including SG&A streamlining, partially offset by growth investments.”
“Cost savings led by CCI program, including SG&A streamlining initiatives, contributed to adjusted operating income growth.”
“Cost savings led by CCI program, including SG&A streamlining initiatives, partially offset by growth investments.”
“Cost savings led by CCI program, including SG&A streamlining initiatives, partially offset by growth investments.”
“Cost savings generated by CCI program partially offset increased SG&A expenses.”
Breaks if: organic sales growth falls below 1% YoY
Sustain and improve organic sales growth by focusing on volume growth and pricing strategies across Consumer and Flavor Solutions segments.
Stated in 6 of last 6 quarters. Organic sales growth ranged from 1.2% to 2% in recent quarters, driven by volume and pricing. Management reaffirmed 2026 guidance for 1% to 3% organic growth. The trajectory shows consistent delivery of modest organic growth aligned with guidance.
“Organic sales growth was 1.7% in the second quarter, driven by volume and pricing.”
“Organic sales growth was 1.2% in the first quarter, driven primarily by price.”
“Organic sales grew 2% in Q4 2025, driven by volume and pricing.”
“Organic sales increased 2% in Q3 2025, volume-led growth.”
“Organic sales increased 2% in Q2 2025, driven by volume and product mix.”
“Organic sales increased 2% in Q1 2025, driven by volume and product mix.”
Breaks if: cost synergies fall below $600 million annual run rate
Advance integration planning for the proposed combination with Unilever Foods to deliver strategic and financial benefits including cost and revenue synergies.
Stated in 2 of last 2 quarters. Management consistently emphasized integration planning for the Unilever Foods combination, targeting $600 million annual run rate cost synergies plus $100 million incremental synergies reinvested for growth. The transaction is expected to be accretive with mid- to high-single-digit EPS accretion in the first year. This priority is delivering as planned with detailed milestones expected by September 2026.
“We are advancing integration planning for the proposed combination with Unilever Foods to realize $600 million annual run rate cost synergies and $100 million incremental synergies.”
“We are making strong progress on integration planning for the proposed Unilever Foods combination and remain confident in delivering expected strategic and financial benefits.”